The FDA has approved Susvimo (ranibizumab injection) for the treatment of patients with diabetic macular edema.
Bayer seeks European approval of extended 6-month treatment interval for Eylea 8 mg to treat nAMD & diabetic macular edema: Berlin Tuesday, February 11, 2025, 10:00 Hrs [IST] Baye ...
Bayer submitted an application to the European Medicines Agency (EMA) to expand treatment intervals of up to 6 months with Eylea™ 8 mg (aflibercept 8 mg, ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback